- Home
- NTGR vs MYGN Comparison
NTGR vs MYGN Comparison
Compare NTGR & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTGR
- MYGN
- Stock Information
- Founded
- NTGR 1996
- MYGN 1991
- Country
- NTGR United States
- MYGN United States
- Employees
- NTGR N/A
- MYGN N/A
- Industry
- NTGR Telecommunications Equipment
- MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- NTGR Utilities
- MYGN Health Care
- Exchange
- NTGR Nasdaq
- MYGN Nasdaq
- Market Cap
- NTGR 776.6M
- MYGN 642.0M
- IPO Year
- NTGR N/A
- MYGN 1995
- Fundamental
- Price
- NTGR $32.11
- MYGN $7.58
- Analyst Decision
- NTGR Strong Buy
- MYGN Hold
- Analyst Count
- NTGR 3
- MYGN 13
- Target Price
- NTGR $34.67
- MYGN $13.50
- AVG Volume (30 Days)
- NTGR 396.6K
- MYGN 1.5M
- Earning Date
- NTGR 10-29-2025
- MYGN 11-06-2025
- Dividend Yield
- NTGR N/A
- MYGN N/A
- EPS Growth
- NTGR N/A
- MYGN N/A
- EPS
- NTGR 2.16
- MYGN N/A
- Revenue
- NTGR $697,865,000.00
- MYGN $832,900,000.00
- Revenue This Year
- NTGR $4.49
- MYGN $0.17
- Revenue Next Year
- NTGR $3.83
- MYGN $6.19
- P/E Ratio
- NTGR $15.06
- MYGN N/A
- Revenue Growth
- NTGR 0.41
- MYGN 3.83
- 52 Week Low
- NTGR $18.75
- MYGN $3.76
- 52 Week High
- NTGR $34.49
- MYGN $26.60
- Technical
- Relative Strength Index (RSI)
- NTGR 65.41
- MYGN 55.60
- Support Level
- NTGR $28.14
- MYGN $7.04
- Resistance Level
- NTGR $34.49
- MYGN $8.25
- Average True Range (ATR)
- NTGR 1.13
- MYGN 0.38
- MACD
- NTGR 0.23
- MYGN -0.05
- Stochastic Oscillator
- NTGR 60.00
- MYGN 45.74
About NTGR NETGEAR Inc.
Netgear Inc provider of networking technologies for businesses, homes, and service providers. It delivers a wide range of intelligent solutions designed to unleash the full potential of connectivity. The group has two segments: NETGEAR for Business and Connected Home which offers reliable, easy-to-use, high-performance networking solutions, including switches, routers, access points, software, and AV over IP technologies, tailored to meet the diverse needs of organizations of all sizes. The Connected Home segment offers connectivity, powerful performance, and enhanced security features right out of the box, designed to help keep families safe online, and Others. It conduct business across three geographic territories: Americas; Europe, Middle East and Africa; and Asia Pacific.
About MYGN Myriad Genetics Inc.
Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.